Sara-Bay Financial’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$280K Hold
3,100
0.07% 77
2026
Q1
$248K Buy
+3,100
New +$256K 0.07% 73
2025
Q4
Sell
-3,387
Closed -$263K 83
2025
Q3
$263K Hold
3,387
0.07% 72
2025
Q2
$265K Sell
3,387
-733
-18% -$54.7K 0.09% 68
2025
Q1
$292K Sell
4,120
-732
-15% -$52.4K 0.13% 66
2024
Q4
$360K Hold
4,852
0.13% 66
2024
Q3
$320K Sell
4,852
-1,162
-19% -$84.4K 0.12% 71
2024
Q2
$556K Hold
6,014
0.23% 57
2024
Q1
$567K Hold
6,014
0.25% 49
2023
Q4
$459K Hold
6,014
0.22% 55
2023
Q3
$417K Hold
6,014
0.21% 55
2023
Q2
$567K Hold
6,014
0.28% 40
2023
Q1
$498K Sell
6,014
-55
-0.9% -$4.32K 0.25% 45
2022
Q4
$453K Hold
6,069
0.25% 50
2022
Q3
$502K Sell
6,069
-500
-8% -$48.1K 0.28% 41
2022
Q2
$630K Sell
6,569
-74
-1% -$7.66K 0.31% 36
2022
Q1
$782K Hold
6,643
0.31% 33
2021
Q4
$861K Hold
6,643
0.26% 35
2021
Q3
$752K Sell
6,643
-10
-0.2% -$1.14K 0.29% 30
2021
Q2
$688K Sell
6,653
-84
-1% -$7.92K 0.26% 34
2021
Q1
$563K Sell
6,737
-397
-6% -$33.6K 0.23% 40
2020
Q4
$651K Sell
7,134
-66
-0.9% -$5.47K 0.29% 33
2020
Q3
$575K Sell
7,200
-2,400
-25% -$187K 0.31% 34
2020
Q2
$623K Buy
+9,600
New +$682K 0.36% 28

Other funds holding EW

Sara-Bay Financial's EW Position: Q2 2026 in Review

Sara-Bay Financial held its Edwards Lifesciences (EW) position steady in Q2 2026 at 3,100 shares worth $280K. The position accounts for 0.07% of the portfolio, ranked #77.

Sara-Bay Financial first reported a position in EW in Q2 2020 and has held it in 24 quarters since. The position peaked at $861K in Q4 2021. 372 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Sara-Bay Financial held 3,100 shares of Edwards Lifesciences worth $280K as of Q2 2026.
  • Sara-Bay Financial left its Edwards Lifesciences share count unchanged in Q2 2026.
  • Edwards Lifesciences made up 0.07% of Sara-Bay Financial's portfolio in Q2 2026, its #77 holding.
  • Sara-Bay Financial first reported a position in Edwards Lifesciences in Q2 2020 and has held it in 24 quarters since.
  • Sara-Bay Financial's Edwards Lifesciences position peaked at $861K in Q4 2021.
  • 372 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Sara-Bay Financial's 13F filing for Q2 2026, filed 17 Jul 2026.